摘要
目的:对18例复发性流产患者采用主动免疫方法,治疗前后进行CD4+CD25+highT细胞、CD4+T细胞、CD8+T细胞水平检测,探讨T细胞群在妊娠期参与调控母体免疫反应中的作用。方法:采用流式细胞仪分别对18例复发性流产患者在流产后初诊时、免疫治疗后3次、孕后免疫治疗2次时其外周血淋巴细胞CD4+CD25+highT细胞、CD4+T细胞、CD8+T比例进行分析。结果:18例复发性流产患者的CD8+T细胞占淋巴细胞初诊时比例为(22.5±1.35)%、免疫治疗后3次比例为(26.10±1.62)%;CD4+CD25+highT细胞占淋巴细胞比例初诊时为(0.98±0.26)%,免疫治疗后3次比例为(1.25±0.35)%;其中12例复发性流产患者孕后免疫治疗2次时的CD8+T占淋巴细胞比例为(29.50±2.20)%,CD4+CD25+highT细胞占淋巴细胞比例为(1.56±0.29)%。结论:主动免疫治疗可以提高外周血CD4+CD25+highT、CD8+T细胞水平,从而调控母胎界面免疫耐受的形成。
Objective: To detect the levels of CD4 ^+ CD25^+ high T cells, CD4^+ T cells and CDs ~ T cells before and after active im- munity among 18 patients with recurrent abortion, explore the function of T cell population in regulation of maternal immune reaction during pregnancy. Methods: Flow cytometry was used to analyze the proportions of CD4^+ CD25 ^+ high T cells, CD4 ^+ T cells and CD8^+ T cells among 18 patients with recurrent abortion at first visit after abortion, after immunotherapy (3 times ) and after postpartum immunotherapy (2 times) . Results: Among 18 patients with recurrent abortion, the proportions of CDs + T cells among lymphocytes at first visit after abortion and after immunotherapy (3 times) were (22. 5 ± 1.35)% and (26. 10 ± 1.62)% , respectively; the proportions of CD4^+ CD25^+ high T cells among lymphocytes at first visit after abortion and after immunotherapy ( 3 times) were ( 0. 98± 0. 26 ) % and ( 1.25 ± 0. 35 ) % , re- spectively. Among 12 patients with recurrent abortion receiving postpartum immunotherapy for 2 times, the proportions of CD8^+ T cells and CD4 ^+ CD25^+high T cells among lymphocytes were (29. 50 ± 2. 20) % and ( 1.56 ± 0, 29 ) % , respectively. Conclusion: Active immuno- therapy can improve the levels of CD4^+ CD25 ^+high T cells and CDS+ T cells in peripheral blood, then it can regulate the formation of immune tolerance on maternal -fetal interface.
出处
《中国妇幼保健》
CAS
北大核心
2011年第29期4546-4547,共2页
Maternal and Child Health Care of China
基金
吴阶平医学基金项目〔320.6750.09083〕